Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workplace Lactation in Neurology: Barriers and Opportunities.

Neurology. Clinical practiceยท2026
Same author

Guidelines for Neuroprognostication in Critically ill Adults with Acute Ischemic Stroke.

Neurocritical careยท2026
Same author

Ethical Challenges, Treatment Decisions, and Research Outcomes in Neurocritical Care.

Neurocritical careยท2026
Same author

Guidelines for Neuroprognostication in Critically Ill Adults with Status Epilepticus.

Neurocritical careยท2026
Same author

Documented Family-Clinician Interactions Prior to Palliative Care Consultation Associated With Less Withdrawal of Life-Sustaining Therapy Among Patients With Traumatic Brain Injury.

The American journal of hospice & palliative careยท2025
Same author

Executive Summary: Society of Critical Care Medicine Clinical Practice Guidelines on Adult End-of-Life Care in the ICU.

Critical care medicineยท2025

Related Experiment Video

Updated: Feb 1, 2026

A Murine Model of Subarachnoid Hemorrhage
07:40

A Murine Model of Subarachnoid Hemorrhage

Published on: November 21, 2013

20.5K

Subarachnoid Hemorrhage.

Susanne Muehlschlegel

    Continuum (Minneapolis, Minn.)
    |December 6, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Aneurysmal subarachnoid hemorrhage (SAH) is a critical neurologic emergency. Improved neurocritical care has reduced mortality, but adherence to guidelines and further research are essential for better patient outcomes.

    More Related Videos

    Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
    10:34

    Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

    Published on: August 30, 2020

    11.5K
    A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
    07:03

    A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

    Published on: January 17, 2013

    14.8K

    Related Experiment Videos

    Last Updated: Feb 1, 2026

    A Murine Model of Subarachnoid Hemorrhage
    07:40

    A Murine Model of Subarachnoid Hemorrhage

    Published on: November 21, 2013

    20.5K
    Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
    10:34

    Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

    Published on: August 30, 2020

    11.5K
    A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
    07:03

    A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

    Published on: January 17, 2013

    14.8K

    Area of Science:

    • Neurology
    • Neurosurgery
    • Critical Care Medicine

    Background:

    • Aneurysmal subarachnoid hemorrhage (SAH) is a severe form of hemorrhagic stroke, presenting a significant neurological emergency with high morbidity and mortality rates.
    • Early recognition and management of SAH and its complications are crucial to prevent secondary brain injury and improve patient prognosis.

    Observation:

    • SAH incidence has remained stable over three decades, but discharge mortality has decreased due to specialized neurocritical care.
    • Current best practices emphasize management in high-volume centers by multidisciplinary teams, prompt intervention for the bleeding source, and neurocritical care unit management.

    Findings:

    • Key recommendations include specialized team management, rapid identification and treatment of the aneurysm, neurocritical care with nimodipine, blood pressure control, and euvolemia.
    • Treatment strategies for cerebral vasospasm/delayed cerebral ischemia involve induced hypertension and endovascular therapies.
    • Recent insights into SAH pathophysiology and updated management approaches are highlighted.

    Implications:

    • SAH necessitates adherence to established guidelines, yet specific management strategies require further investigation through clinical trials.
    • Continued research is vital to refine controversial approaches and optimize patient outcomes in SAH management.